Fujirebio, Stem Cell Sciences To Co-develop Serum-free Mediums For Stem Cell Culture
10/19/2005 5:11:03 PM
Fujirebio (TSE: 4544) has announced that it has entered into a joint development agreement with Stem Cell Sciences.
Under this agreement, the two companies will develop serum-free mediums to be used to culture and differentiate stem cells.
The discovery may pave the way for the progress of regeneration medicine.